Beta Bionics Does the Work to Reduce Insulin Pump Burden

This podcast features Matt Henriksson from Bloomberg Intelligence interviewing Sean Saint, CEO of Beta Bionics, about automated insulin delivery systems. They discuss Sean's background in the diabetes technology industry, the evolution of insulin delivery methods, and the unique features of Beta Bionics' iLet pump, including its ease of use and algorithm-based personalization. The conversation covers clinical trial data, the transition to a pharmacy channel with a pay-as-you-go model, and future developments like the on-the-body patch pump and bihormonal system. They also touch on Beta Bionics' approach to balancing growth with responsible financial management.